Tandem Diabetes Care, Inc.: Tandem pumps are battery-operated infusion pumps capable of both basal and bolus delivery of insulin. The pumps utilize a motor-driven mecha
Read the official notice at FDA (device) →
Get alerts for Tandem Diabetes Care
The text below is copied from the official FDA (device) record. If anything differs, the official notice is correct.
- Company / brand
- Tandem Diabetes Care, Inc.
- Product
- Tandem pumps are battery-operated infusion pumps capable of both basal and bolus delivery of insulin. The pumps utilize a motor-driven mechanism to deliver insulin from within a disposable cartridge, through an infusion set, into a patient s subcutaneous tissue. As with current insulin infusion pumps on the U.S. market, the desired timing and quantity of the insulin delivery is programmed by the user (i.e., the patient).
- Reason / hazard
- The Czech language user guide contained multiple translation errors. The most significant error was that it incorrectly instructs users to verify that the infusion set is connected to the body, when it should instead direct users to confirm that the infusion set is not connected to the body. Following this instruction could result in unintended insulin delivery, potentially leading to a hypoglycemic event.
- Classification
- Class II
- Status
- Ongoing
- Distribution / sold at
- International distribution in the countries of Czech Republic, Slovakia.
- Recall initiated
- 2026-01-30
- Code info
- Version 7.8.1/ UDI: (01)008500066132625
- Product quantity
- 1,380 units
- Voluntary mandated
- Voluntary: Firm initiated
- City
- San Diego
- State
- CA
- Country
- United States
- Event id
- 98478
Free daily digest + "My products" watchlist